Study Attribute | Value |
---|---|
CEBS Accession Number: | 002-01254-0002-0000-6 |
Chemical Name: | 2,6-Toluenediamine dihydrochloride (2,6-diaminotoluene dihydrochloride) |
CASRN: | 15481-70-6 |
NTP Study Type: | Genetic Toxicology - Mammalian Cell Cytogenetics |
NTP Study ID: | 717361_CA |
Study Result: | Positive |
Activation | Trial | Trial Call |
---|---|---|
No Activation | 1 | Negative |
Induced Rat Liver S9 | 1_S9 | Negative |
No Activation | 2 | Weakly Positive* |
Induced Rat Liver S9 | 2_S9 | Negative |
No Activation | 3 | Weakly Positive |
No Activation | 4 | Positive |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 4 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 4 | 0.020 | 2.0 | 0 | 0.000 | 0.0 |
Test Chemical: | 2,6-Toluenediamine dihydrochloride (2,6-diaminotoluene dihydrochloride) | 500 | 200 | 8 | 0.040 | 3.5 | 2 | 0.010 | 1.0 | 6 | 0.030 | 2.5 | 0 | 0.000 | 0.0 |
1000 | 200 | 9 | 0.045 | 4.0 | 1 | 0.005 | 0.5 | 8 | 0.040 | 3.5 | 0 | 0.000 | 0.0 | ||
1600 | 200 | 4 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | 4 | 0.020 | 2.0 | 0 | 0.000 | 0.0 | ||
3000 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.063 | 200 | 37 | 0.185 | 14.5 | 14 | 0.070 | 6.5 | 23 | 0.115 | 9.5 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.25 | 50 | 8 | 0.160 | 14.0 | 1 | 0.020 | 2.0 | 6 | 0.120 | 12.0 | 1 | 0.020 | 1.0 | |
Trend: | 0.180 | -0.217 | 0.277 | ||||||||||||
Probability: | 0.429 | 0.586 | 0.391 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 |
Test Chemical: | 2,6-Toluenediamine dihydrochloride (2,6-diaminotoluene dihydrochloride) | 500 | 200 | 3 | 0.015 | 1.5 | 1 | 0.005 | 0.5 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 |
1000 | 200 | 8 | 0.040 | 2.5 | 0 | 0.000 | 0.0 | 8 | 0.040 | 2.5 | 0 | 0.000 | 0.0 | ||
1600 | 200 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | ||
3000 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 200 | 50 | 0.250 | 20.5 | 13 | 0.065 | 6.5 | 37 | 0.185 | 16.5 | 0 | 0.000 | 0.0 |
Cyclophosphamide | 10 | 50 | 19 | 0.380 | 36.0 | 5 | 0.100 | 10.0 | 14 | 0.280 | 28.0 | 0 | 0.000 | 0.0 | |
Trend: | 0.785 | -0.470 | 0.973 | ||||||||||||
Probability: | 0.216 | 0.681 | 0.165 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Medium | 0 | 200 | 5 | 0.025 | 2.5 | 2 | 0.010 | 1.0 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 |
Test Chemical: | 2,6-Toluenediamine dihydrochloride (2,6-diaminotoluene dihydrochloride) | 100 | 200 | 6 | 0.030 | 2.5 | 0 | 0.000 | 0.0 | 6 | 0.030 | 2.5 | 0 | 0.000 | 0.0 |
250 | 200 | 8 | 0.040 | 4.0 | 2 | 0.010 | 1.0 | 6 | 0.030 | 3.0 | 0 | 0.000 | 0.0 | ||
500 | 200 | 24 | 0.120 | 12.0 | 2 | 0.010 | 1.0 | 22 | 0.110 | 11.0 | 0 | 0.000 | 0.0 | ||
1000 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.063 | 200 | 94 | 0.470 | 33.5 | 51 | 0.255 | 20.5 | 43 | 0.215 | 17.0 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.125 | 50 | 47 | 0.940 | 58.0 | 32 | 0.640 | 42.0 | 15 | 0.300 | 22.0 | 0 | 0.000 | 0.0 | |
Trend: | 4.163 | 0.400 | 4.312 | ||||||||||||
Probability: | 0.000 | 0.345 | 0.000 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 3 | 0.015 | 1.5 | 2 | 0.010 | 1.0 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 |
Test Chemical: | 2,6-Toluenediamine dihydrochloride (2,6-diaminotoluene dihydrochloride) | 1000 | 200 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 |
1500 | 200 | 2 | 0.010 | 1.0 | 2 | 0.010 | 1.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
2000 | 200 | 6 | 0.030 | 2.5 | 3 | 0.015 | 1.5 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 | ||
Positive Control: | Cyclophosphamide | 7.5 | 200 | 293 | 1.465 | 77.5 | 98 | 0.490 | 39.5 | 185 | 0.925 | 60.0 | 10 | 0.050 | 1.0 |
Cyclophosphamide | 15 | 50 | 164 | 3.280 | 98.0 | 36 | 0.720 | 58.0 | 78 | 1.560 | 76.0 | 50 | 1.000 | 5.0 | |
Trend: | 0.899 | 0.847 | 0.901 | ||||||||||||
Probability: | 0.184 | 0.198 | 0.184 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 |
Test Chemical: | 2,6-Toluenediamine dihydrochloride (2,6-diaminotoluene dihydrochloride) | 250 | 200 | 4 | 0.020 | 2.0 | 1 | 0.005 | 0.5 | 3 | 0.015 | 1.5 | 0 | 0.000 | 0.0 |
500 | 200 | 7 | 0.035 | 3.5 | 0 | 0.000 | 0.0 | 7 | 0.035 | 3.5 | 0 | 0.000 | 0.0 | ||
1000 | 200 | 14 | 0.070 | 7.0 | 2 | 0.010 | 1.0 | 12 | 0.060 | 6.0 | 0 | 0.000 | 0.0 | ||
1500 | 0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.063 | 200 | 77 | 0.385 | 28.0 | 42 | 0.210 | 17.0 | 35 | 0.175 | 14.5 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.125 | 50 | 47 | 0.940 | 54.0 | 30 | 0.600 | 42.0 | 17 | 0.340 | 26.0 | 0 | 0.000 | 0.0 | |
Trend: | 3.130 | 1.293 | 2.852 | ||||||||||||
Probability: | 0.001 | 0.098 | 0.002 |
Dose µg/mL | Total Cells Examined | Total Aberrations | Complex Aberrations | Simple Aberrations | Other Abs | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. of Abs | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | No. of Abs. | Abs Per Cell | % Cells With Abs | ||||
Vehicle Control: | Negative (Not Specified) | 0 | 200 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 | 1 | 0.005 | 0.5 | 0 | 0.000 | 0.0 |
Test Chemical: | 2,6-Toluenediamine dihydrochloride (2,6-diaminotoluene dihydrochloride) | 250 | 200 | 15 | 0.075 | 7.5 | 0 | 0.000 | 0.0 | 15 | 0.075 | 7.5 | 0 | 0.000 | 0.0 |
500 | 200 | 10 | 0.050 | 5.0 | 1 | 0.005 | 0.5 | 9 | 0.045 | 4.5 | 0 | 0.000 | 0.0 | ||
1000 | 200 | 35 | 0.175 | 12.0 | 10 | 0.050 | 4.0 | 25 | 0.125 | 9.5 | 0 | 0.000 | 0.0 | ||
1500 | 104 | 50 | 0.481 | 28.8 | 4 | 0.038 | 3.8 | 46 | 0.442 | 26.0 | 0 | 0.000 | 0.0 | ||
Positive Control: | Mitomycin-C | 0.063 | 200 | 68 | 0.340 | 28.0 | 18 | 0.090 | 9.0 | 50 | 0.250 | 22.5 | 0 | 0.000 | 0.0 |
Mitomycin-C | 0.125 | 50 | 46 | 0.920 | 54.0 | 12 | 0.240 | 20.0 | 24 | 0.480 | 40.0 | 10 | 0.200 | 1.0 | |
Trend: | 7.108 | 4.012 | 6.302 | ||||||||||||
Probability: | 0.000 | 0.000 | 0.000 |